These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23984511)

  • 1. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
    Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
    J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
    Borroni RG
    G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
    Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
    HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
    Aoki S
    Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.
    Ramsbottom KA; Carr DF; Jones AR; Rigden DJ
    Mol Immunol; 2018 Sep; 101():488-499. PubMed ID: 30125869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and Delayed Drug-Induced Hypersensitivity.
    Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
    Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen and idiosyncratic adverse drug reactions.
    Usui T; Naisbitt DJ
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):21-30. PubMed ID: 28017537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
    Xiong Y; Zhang W; Chen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):749-57. PubMed ID: 25080918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Association with Drug-Induced Adverse Reactions.
    Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
    J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*1502 screening and toxic effects of carbamazepine.
    Phillips EJ; Mallal SA
    N Engl J Med; 2011 Aug; 365(7):672; author reply 673. PubMed ID: 21848472
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.